ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.97
0.34%
US Tech 100
19,474.00
-0.03%
S&P 500
5,509.01
0.62%
US Dollar vs CAD
1.36745
-0.02%
Bitcoin
60,850.49
-1.90%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Targeted Genetics Corp (TGEND)

  7. Targeted Genetics Corp (TGEND) News

TGEND

Targeted Genetics (TGEND)

Targeted Genetics Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TGEND
DateTimeSourceHeadlineSymbolCompany
06/05/20067:00AMBusiness WireEncouraging Interim Results from a Phase I/II Trial of Targeted Genetics' tgAAC94 in Patients with Inflammatory Arthritis; InteNASDAQ:TGENDTargeted Genetics Corp
06/05/20066:45AMBusiness WireTargeted Genetics Enhances Inflammatory Arthritis Product Development PlatformNASDAQ:TGENDTargeted Genetics Corp
06/05/20066:30AMBusiness WireTargeted Genetics and Collaborators Advance Key Technologies For AAV-Based Product DevelopmentNASDAQ:TGENDTargeted Genetics Corp
06/02/20067:00AMBusiness WireTargeted Genetics Advances Its Manufacturing Leadership; Additional Manufacturing Capabilities Reported at Scientific MeetingNASDAQ:TGENDTargeted Genetics Corp
06/01/20067:00AMBusiness WireTargeted Genetics Presents Encouraging Interim Data From an Ongoing Phase I/II Trial of tgAAC94 in Patients with Inflammatory ANASDAQ:TGENDTargeted Genetics Corp
05/25/20066:30AMBusiness WireTargeted Genetics Highlights Inflammatory Arthritis Program and Robust AAV Product Development Platform at the American SocietyNASDAQ:TGENDTargeted Genetics Corp
05/11/20066:30AMBusiness WireTargeted Genetics Announces One-for-Ten Reverse Stock SplitNASDAQ:TGENDTargeted Genetics Corp
 Showing the most relevant articles for your search:NASDAQ:TGEND

Your Recent History

USOTC
NNAX
New Momentum (PK)
NASDAQ
TSLA
Tesla
USOTC
ASKH
Astika (PK)
USOTC
CNNA
Cann American (CE)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
PHIL
PHI (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
HMBL
HUMBL (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
AXXA
Exxe (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
RXMD
Progressive Care (QB)
USOTC
GGSM
Gold and GemStone Mining (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved